t
Diaceutics PLC announced on 29 May 2026 that it has posted its Annual Report for the year ended 31 December 2025 and the Notice of its 2026 Annual General Meeting (AGM) to shareholders. The company will hold its AGM on Thursday, 25 June 2026, at 10.30am.
| Date | 29 May 2026 |
| Time | 14:00:00 |
| Category | AGMs and other meetings |
| ID | 2877G |
Diaceutics PLC
Notice of AGM and Posting of Annual Report
New York, Belfast and London, 29 May 2026 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry, announces that it has today posted its Annual Report for the year ended 31 December 2025 to shareholders together with the Notice of the 2026 Annual General Meeting ("AGM").
The Company will hold its AGM on Thursday, 25 June 2026 at 10.30am at First Floor, Building Two, Dataworks at Kings Hall Health and Wellbeing Park, Belfast, County Antrim BT9 6GW.
The Annual Report and Notice of AGM will also be available shortly on the Company's website at www.diaceutics.com
Enquiries:
|
Diaceutics PLC |
|
|
Ryan Keeling, Chief Executive Officer Nick Roberts, Chief Financial Officer |
Tel: +44 (0)28 9040 6500
|
|
|
|
|
Canaccord Genuity Limited (Nomad & Broker) |
Tel: +44 (0)20 7523 8000 |
|
Simon Bridges, Andrew Potts, Harry Rees |
|
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.